Sign in
4

Changes in Ownership

Sana Biotechnology, Inc. Filed Acc 0001562180-22-002428

Options or other derivatives

  • Head of SanaX acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mulligan Richard · Head of SanaX

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-03 Grant or award : show line 1 in the form Stock Options (Right to Buy) +250,000 250,000 D
Loading xslF345X03/primarydocument.xml…